Ticker Details
Lifecore Biomedical, Inc.
IPO Date:	March 1, 1996
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$267.14M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 2.86%
Avg Daily Range (30 D):	$0.17 | 2.09%
Avg Daily Range (90 D):	$0.16 | 2.13%

Institutional Daily Volume
Avg Daily Volume:	.24M
Avg Daily Volume (30 D):	.11M
Avg Daily Volume (90 D):	.12M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	30
Avg Institutional Trade:	$2.84M
Avg Institutional Trade (30 D):	$.89M
Avg Institutional Trade (90 D):	$.89M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.68M
Avg Closing Trade (30 D):	$.89M
Avg Closing Trade (90 D):	$.89M
Avg Closing Volume:	639.34K

News

Jan 16, 2026 @ 9:45 PM Lifecore Announces Inducement Grants Under Nasdaq ... Source: Na

Dec 17, 2025 @ 12:00 PM Lifecore Biomedical Signs CDMO Master Services Agr... Source: Paul Josephs

Oct 13, 2025 @ 11:00 AM Lifecore Biomedical to Participate at Upcoming Ind... Source: Lifecore Biomedical, Inc.

Sep 27, 2025 @ 12:31 PM LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squir... Source: Bragar Eagel & Squire, P.C.

Aug 15, 2025 @ 12:42 AM LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Inv... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.29	$-.03	$-1.27
Diluted EPS	$-.29	$-.03	$-1.27
Revenue	$31.11M	$36.44M	$128.87M
Gross Profit	$7.79M	$13.98M	$40.3M
Net Income / Loss	$-9.99M	$-1.15M	$-38.72M
Operating Income / Loss	$-3.07M	$5.33M	$-17.25M
Cost of Revenue	$23.32M	$22.46M	$88.57M
Net Cash Flow	$-1.36M	$2.85M	$-.2M
PE Ratio